Atlas Trials

Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Clinical trial NCT00004248 · COMPLETED

Trial details

NCT number
NCT00004248
Sponsor
Roswell Park Cancer Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Cancer
Start date
1999-07-01
Primary completion
2000-06-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.